Cite
HARVARD Citation
Bénard, F. et al. (2022). Intra-individual comparison of 18F-sodium fluoride PET–CT and 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial. Lancet oncology. 23 (12), pp. 1499-1507. [Online].